一拖股份(601038.SH):2023年公司預計出口銷量將繼續較大幅度增長
格隆匯6月14日丨有投資者向一拖股份(601038.SH)提問:公司出口市場的區域及2023年的市場目標?公司出口產品的銷售模式、結算方式、毛利率水平?
一拖股份回覆:2022年公司出口4600餘台,其中俄語區佔比超過50%,也呈現快速增長。2023年公司預計出口銷量將繼續較大幅度增長。
目前公司海外銷售模式主要是經銷商代理、渠道銷售模式;出口業務以全款付款結算為主,在俄語區等市場主要以人民幣結算;出口產品毛利率基本和國內持平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.